Kehua Biotech announced that the net loss attributable to shareholders of listed companies from January 1, 2026 to June 30, 2026 is estimated to be 82 million yuan to 115 million yuan, compared with a loss of 133 million yuan for the same period last year. Facing multiple policy pressures such as continuous implementation of collection policies in the IVD industry, accelerated implementation of DRG/DIP payment methods, expansion of the scope of mutual recognition of inspection results, and price adjustments, the company actively responds and actively adjusts. By optimizing product market strategies and deepening regional management of the marketing team, the company continues to strengthen customer coverage and maintenance capabilities, and focuses on improving customer service quality and response efficiency to help the company expand the market. At the same time, the company continues to further promote lean production management, optimize resource allocation around cost reduction and efficiency, accelerate the digital transformation of management, and gradually improve process automation and management efficiency.

Kehua Biotech announced that the net loss attributable to shareholders of listed companies from January 1, 2026 to June 30, 2026 is estimated to be 82 million yuan to 115 million yuan, compared with a loss of 133 million yuan for the same period last year. Facing multiple policy pressures such as continuous implementation of collection policies in the IVD industry, accelerated implementation of DRG/DIP payment methods, expansion of the scope of mutual recognition of inspection results, and price adjustments, the company actively responds and actively adjusts. By optimizing product market strategies and deepening regional management of the marketing team, the company continues to strengthen customer coverage and maintenance capabilities, and focuses on improving customer service quality and response efficiency to help the company expand the market. At the same time, the company continues to further promote lean production management, optimize resource allocation around cost reduction and efficiency, accelerate the digital transformation of management, and gradually improve process automation and management efficiency.